Clinical Trials Browser

Phase 2 × Interventional × Immunologic Factors × Clear all

NCT05182957 2023-01-31

Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT02976740 2016-11-29

SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy

Phase 2 Unknown

Lung Neoplasms